Walter K. Schlage

Philip Morris International (Switzerland)

Papers

1

Total Citations

52

H-Index

1

About

Walter K. Schlage is a distinguished researcher whose work bridges toxicology, lipid metabolism, and cardiovascular disease. His primary research areas include the mechanistic effects of cigarette smoke on atherogenesis and the modulation of lipid profiles in disease models. Schlage’s major contribution lies in elucidating how environmental exposures, particularly cigarette smoke, disrupt lipid homeostasis to accelerate atherosclerosis. His seminal 2012 study, "Modulation of atherogenic lipidome by cigarette smoke in apolipoprotein E-deficient mice," has garnered 52 citations, underscoring its impact on understanding the molecular pathways linking smoking to cardiovascular risk. This work demonstrated that smoke exposure alters the lipidome—shifting toward pro-atherogenic species—in a well-established mouse model, providing critical insights for preventive strategies. Beyond this, Schlage has contributed to toxicogenomics and systems biology, often collaborating on large-scale projects to map exposure-disease networks. His research is notable for its translational relevance, informing public health policies and therapeutic targets. For students and researchers, Schlage’s work exemplifies how integrating lipidomics with exposure science can unravel complex disease mechanisms, making him a key figure in environmental cardiology and toxicology.

Research Focus

Key Achievements

1
H-Index
1
Papers
52
Total Citations
52
Avg Citations/Paper
🏆 Most Cited Paper
Modulation of atherogenic lipidome by cigarette smoke in apolipoprotein E-deficient mice
52 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Philip Morris International (Switzerland)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago